Episode Details
Back to Episodes
Med-X Targets Global Pest Control Market as It Prepares for NASDAQ Listing (reserved ticker: MXRX)
Description
In this episode of The Watchlist, Ricki Lee speaks with Matthew Mills, Chairman and CEO of Med-X, about the company's Nature-Cide line of naturally derived pest control products and its ambitions to expand across the professional pest control market.
Listeners will hear how Med-X is approaching conventional pesticide use, where Nature-Cide is currently being distributed, and how the company is building relationships across professional pest control, vector control, commercial, residential and agricultural applications.
This discussion covers:
- Nature-Cide's plant-based approach to pest control
- Med-X's expanding U.S. distribution network and international ambitions
- The company's strategic relationship with Mainline Brands, including Mosquito Authority and Pest Authority
- The potential impact of a NASDAQ listing under the reserved ticker MXRX
- Med-X's plans for marketing, acquisitions and international expansion
This podcast is made in partnership with Med-X. This podcast is for informational purposes only. Please do your own due diligence. For our full disclaimer, visit: https://stockhouse.com/legal/disclaimer
#MedX #MXRX #PestControl #Biotechnology #Investing #NASDAQ #HealthAndWellness
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.